Patents for A61P 19 - Drugs for skeletal disorders (81,981)
03/2008
03/12/2008EP1897870A1 Pharmaceutical composition comprising 2-pyridone derivative as active ingredient
03/12/2008EP1897553A1 Inhibitor of stem cell proliferation and uses thereof
03/12/2008EP1897551A1 Health food and pharmaceutical composition for amelioration of disease induced by metabolic disorder in cartilage
03/12/2008EP1897441A1 TGF-alpha polypeptides, functional fragments and methods of use therefor
03/12/2008EP1896585A2 Double-stranded synthetic oligonucleotides useful for inducing apoptosis of osteoclasts for the treatment of osteopenic pathologies
03/12/2008EP1896393A1 The treatment of inflammatory disorders and pain
03/12/2008EP1896134A2 Methods and compositions for treating degenerative bone disorders
03/12/2008EP1896072A2 A direct drug delivery system based on thermally responsive biopolymers
03/12/2008EP1896053A1 Pharmaceutical composition comprising fgf18 and il-1 antagonist and method of use
03/12/2008EP1896035A2 Carbazole formulations for the treatment of psoriasis and angiogenesis
03/12/2008EP1896020A1 Inhibition of osteolytic lesions by src kinase inhibitors
03/12/2008EP1896012A2 Anti-inflammatory agents
03/12/2008EP1895947A2 Improved method of treating degenerative spinal disorders
03/12/2008EP1763515B1 4-trifluoromethoxyphenoxybenzol-4'-sulfonic acids, method for the production and use thereof in medicaments
03/12/2008EP1560815B1 Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases
03/12/2008EP1539693B1 Cannabinoid receptor agonists
03/12/2008EP1534275B1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
03/12/2008EP1495009B1 Cyanamides useful as reversible inhibitors of cysteine proteases
03/12/2008EP1408999B1 Compositions addressing inflammation and/or degenerative disorders
03/12/2008EP0614374B2 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES
03/12/2008CN201033171Y Medicine label for treating arthralgia
03/12/2008CN101142218A Pyrrolopyrimidines useful as inhibitors of protein kinase
03/12/2008CN101141976A Local treatment of bone defects with matrix releasing bmp or pth
03/12/2008CN101141960A Methods and compositions using 4-amino-2-(3-methyl-2,6-dioxopiperidin-3-yl)-isoindole-1-3-dione
03/12/2008CN101141956A Use of CRTH2 antagonist compounds in therapy
03/12/2008CN101139361A Targeting osteoporosis-resistant drug and preparation method thereof
03/12/2008CN101139343A Synthesis of piperidine and piperazine compounds as ccr5 antagonists
03/12/2008CN101138631A Novel recombinant parathyroid hormone (1-34) correlated peptide nose drops
03/12/2008CN101138626A Bone-through ache-treating emplastrum
03/12/2008CN101138625A Chinese medicine composition for treating omarthritis
03/12/2008CN101138617A Multiple-effect paste for activating blood circulation and removing stasis
03/12/2008CN101138602A Kidney-nourishing gout-treating capsule
03/12/2008CN101138597A Traditional Chinese medicine preparation for preventing and controlling osteoporosis and method of preparing the same
03/12/2008CN101138594A Quality control method of traditional chinese medicine preparation for treating traumatic injury and rheumatism ostealgia
03/12/2008CN101138571A Hyperosteogeny-against and rheumatism-against inunction agentia
03/12/2008CN101138566A Prevention and treatment process for infectious diseases and other diseases by using immunity effect compounds
03/12/2008CN100374550C Magnetic cell and method of using the same
03/12/2008CN100374466C Antibodies against human IL-12
03/12/2008CN100374443C Hydrophilic polymer-thunder good vine extract binding substance and its medicinal composition
03/12/2008CN100374435C Substd. pyridines and pyridazines with angiogenesis inhibiting activity
03/12/2008CN100374416C P-(sulfonyl)-aryl and heteroaryls amines
03/12/2008CN100374105C Glabrous sarcandra herb lyophilized powder for injection, its high-dose injection and preparing method
03/11/2008US7342034 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
03/11/2008US7342029 Substituted indoles
03/11/2008US7342020 Effective against MMP 9 and 13; arthritis, atherosclerosis; synthesis
03/11/2008US7341995 Use of SARP-1 for the treatment and/or prevention of scleroderma
03/11/2008US7341871 Recombinant expression vector comprising promoter sequence, age regulatory sequence; can use in treatment of age-related and liver diseases; operably linking nucleic acid sequence, promoter sequence, and age regulatory sequences to produce a transgene, introducing into cell
03/11/2008CA2407747C Gel-like pharmaceutical composition for subcutaneous administration comprising bisphosphonic acids or their salts
03/11/2008CA2382489C Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
03/11/2008CA2335104C Arylalkanoylpyridazines
03/11/2008CA2192764C Integrin receptor antagonists
03/06/2008WO2008027812A2 Imidazopyridine and imidazopyrimidine derivatives
03/06/2008WO2008026907A1 Pharmaceutical composition comprising ibandronate and vitamin d3 for the treatment of osteoporosis
03/06/2008WO2008026729A1 Therapeutic agent for pigmented villonodular synovitis or giant cell tumor of tendon sheath or bone
03/06/2008WO2008026704A1 Isoquinoline derivative
03/06/2008WO2008025822A1 Diazolodiazine derivatives as kinase inhibitors
03/06/2008WO2008025069A1 Methods of modulating cellular activity and compositions therefor
03/06/2008WO2008003855A3 Use of 2-benzoyl-imidazopyridines in therapeutics
03/06/2008WO2007134867A3 Treating muscular disorders and improving muscular function
03/06/2008WO2007100643A3 Methods of using antibodies against human il-22
03/06/2008US20080058505 Modified parathyroid hormone/peptides for use in prevention and treatment of bone disorders
03/06/2008US20080058415 Lipid Preparation for Enhancing Mineral Absorption
03/06/2008US20080058382 Polyamine compounds
03/06/2008US20080058361 Tetrahydrobenzfluorene derivatives
03/06/2008US20080058359 1-[[3-[(1,4,5,6-Tetrahydro-2-pyrimidinyl)amino]phenyl]acetyl]-4-piperidinepropanoic acid; new class of selective modulator of beta 3, beta 5 or dual integrin receptors; anticarcinogenic, antiinflammatory, antidiabetic agent
03/06/2008US20080058350 Imidazopyridine and imidazopyrimidine derivatives
03/06/2008US20080058348 Bone disorders such as osteoporosis, tumors and cardiovascular disorders; 4-(2-carboxy-2-Boc-aminoethylamino)-6-piperidinopyrimidines such as tert-butyl 2-benzyloxycarbonylamino-3-[2,5-dimethoxy-6-(4-[1,8]naphthyridin-2-yl-piperidin-1-yl)pyrimidin-4-ylamino]-propionate
03/06/2008US20080058337 Pyrrolotriazine kinase inhibitors
03/06/2008US20080058333 Carbamates such as (1-benzylcyclohexyl)methyl(1S)-5-[(4-morpholinylcarbonyl)amino]-1-(oxo([(1R)-1-phenylethyl]amino)acetyl)pentylcarbamate; osteoporosis
03/06/2008US20080058325 Compounds, methods and pharmaceutical compositions for inhibiting parp
03/06/2008US20080058312 Modulators of hepatocyte growth factor/c-Met activity
03/06/2008US20080058299 Method of treating or preventing bone deterioration or osteoporosis
03/06/2008US20080058263 Polypeptides that binds to cellular receptors; animal growth regukators
03/06/2008US20080057515 Beta-like glycoprotein hormone polypeptide and heterodimer
03/06/2008US20080057109 Bifidobacterium longum infantis strain secretes a factor that antagonizes the activity ofpro-inflammatory cytokine selected from TNF- alpha, IL-8, IFN gamma to treat inflammatory bowel disease or irritable bowel syndrome
03/06/2008US20080057095 Bone semi-permeable device
03/06/2008US20080057070 Antagonist Anti-Cd40 Monoclonal Antibodies and Methods for Their Use
03/06/2008US20080057055 Human polynucleotide phosphorylase (hPNPaseold-35 or OLD-35); arthritis, atherosclerosis and Alzheimer's disease
03/06/2008US20080057051 Method for fostering bone formation and preservation
03/06/2008US20080057048 Non-immunognic polyethylene glycol conjugated therapeutic uricase for use in treatment of kidney and inflammatory disorders
03/06/2008US20080057025 Method for promoting bone formation
03/05/2008EP1893191A1 Medicinal acidic cannabinoids
03/05/2008EP1045836B1 Pyridones as src family sh2 domain inhibitors
03/05/2008EP0989993B1 Tartrate salt of a substituted dipeptide as growth hormone secretagogue
03/05/2008CN101137656A Crystal forms of an imidazole derivative
03/05/2008CN101137655A Androgen receptor modulator compounds and methods
03/05/2008CN101137644A 7-(2-(4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydropyrid-1-yl)ethyl)isoquinoline besylate salt, preparation and therapeutic use thereof
03/05/2008CN101137414A 多环双酰胺mmp抑制剂 Polycyclic bisamides mmp inhibitors
03/05/2008CN101137382A Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
03/05/2008CN101134068A Externally used drug for treating arthralgia and soft tissue injury and method for preparing the same
03/05/2008CN101134062A Specific analgesic liniment
03/05/2008CN101134044A Composition based on salts of hyaluronic acid for treating epithelial lesions
03/05/2008CN101134011A Human body skin damnification renovating injection
03/05/2008CN101134003A Specific wrinkle removing agent
03/05/2008CN100372849C Pyrrolo pyrimidine compounds as inhibitor of cysteine protease
03/05/2008CN100372836C Immunotherapeutic imides/amides
03/04/2008US7338659 Reducing immunogenicities of immunoglobulins by framework-patching
02/2008
02/28/2008WO2008024981A1 Piperazine-substituted benzothiophenes for treatment of mental disorders
02/28/2008WO2008024784A1 Alkylsulfonamide-substituted triazoles as matrix metalloprotease inhibitors
02/28/2008WO2008024391A1 Pharmaceutical formulations of an indole-type derivative and related methods of use